Recurrent cerebral ischemia in medically treated patent foramen ovale: A meta-analysis

Neurology

Volumn 73, Issue 2, 2009, Pages 89-97

  Almekhlafi, M A ^a   Wilton, S B ^a   Rabi, D M ^a,b   Ghali, W A ^a,b   Lorenzetti, D L ^a   Hill, M D ^a,b,c  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c FOOTHILLS HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CEREBROVASCULAR ACCIDENT; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; OUTCOME ASSESSMENT; PATENT FORAMEN OVALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SYSTEMATIC REVIEW; TRANSIENT ISCHEMIC ATTACK; AGE; BRAIN ISCHEMIA; META ANALYSIS; MORTALITY; REVIEW; RISK; STROKE; TREATMENT OUTCOME;

AGE FACTORS; BRAIN ISCHEMIA; FORAMEN OVALE, PATENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; RECURRENCE; RISK; STROKE; TREATMENT OUTCOME;

EID: 68149096632     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181aa2a19     Document Type: Article

References (39)

1. Sacco RL, Ellenberg JH, Mohr JP, et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 1989;25:382-390.
2. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc 1984;59:17-20.
3. Lechat P, Mas JL, Lascault G, et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 1988;318:1148-1152.
4. Handke M, Harloff A, Olschewski M, Hetzel A, Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 2007;357:2262-2268.
5. Srivastava TN, Payment MF. Images in clinical medicine: paradoxical embolism-thrombus in transit through a patent foramen ovale. N Engl J Med 1997;337:681.
6. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008-2012.
7. Egger MSG, Schneider M. Systematic reviews of observational studies. In: Egger MSG, Altman DG, ed. Systematic Reviews in Health Care: Meta-analysis in Context., 2nd ed. London: BMJ Publishing Group; 2005:211-227.
8. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144:427-437.
9. Hanna JP, Sun JP, Furlan AJ, Stewart WJ, Sila CA, Tan M. Patent foramen ovale and brain infarct: echocardiographic predictors, recurrence, and prevention. Stroke 1994;25:782-786.
10. Casaubon L, McLaughlin P, Webb G, Yeo E, Merker D, Jaigobin C. Recurrent stroke/TIA in cryptogenic stroke patients with patent foramen ovale. Can J Neurol Sci 2007;34:74-80.
11. Cujec B, Mainra R, Johnson DH. Prevention of recurrent cerebral ischemic events in patients with patent foramen ovale and cryptogenic strokes or transient ischemic attacks. Can J Cardiol 1999;15:57-64.
12. De Castro S, Cartoni D, Fiorelli M, et al. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke 2000;31:2407-2413.
13. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 2002;105:2625-2631.
14. Mas JL, Arquizan C, Lamy C, et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 2001;345:1740-1746.
15. Anzola GP, Zavarize P, Morandi E, Rozzini L, Parrinello G. Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. Eur J Neurol 2003;10:129-135.
16. Bogousslavsky J, Garazi S, Jeanrenaud X, Aebischer N, Van Melle G. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study: Lausanne Stroke with Paradoxal Embolism Study Group. Neurology 1996;46:1301-1305.
17. Cerrato P, Priano L, Imperiale D, et al. Recurrent cerebrovascular ischaemic events in patients with interatrial septal abnormalities: a follow-up study. Neurol Sci 2006;26:411-418.
18. Harrer JU, Wessels T, Franke A, Lucas S, Berlit P, Klotzsch C. Stroke recurrence and its prevention in patients with patent foramen ovale. Can J Neurol Sci 2006;33:39-47.
19. Hausmann D, Mugge A, Daniel WG. Identification of patent foramen ovale permitting paradoxic embolism. J Am Coll Cardiol 1995;26:1030-1038.
20. Mas JL, Zuber M. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack: French Study Group on Patent Foramen Ovale and Atrial Septal Aneurysm. Am Heart J 1995;130:1083-1088.
21. Schuchlenz HW, Weihs W, Berghold A, Lechner A, Schmidt R. Secondary prevention after cryptogenic cerebrovascular events in patients with patent foramen ovale. Int J Cardiol 2005;101:77-82.
22. Thanopoulos BV, Dardas PD, Karanasios E, Mezilis N. Transcatheter closure versus medical therapy of patent foramen ovale and cryptogenic stroke. Catheter Cardiovasc Interv 2006;68:741-746.
23. Windecker S, Wahl A, Nedeltchev K, et al. Comparison of medical treatment with percutaneous closure of patent foramen ovale in patients with cryptogenic stroke. J Am Coll Cardiol 2004;44:750-758.
24. Serena J, Marti-Fabregas J, Santamarina E, et al. Recurrent Stroke and Massive Right-to-Left Shunt: Results From the Prospective Spanish Multicenter (CODICIA) Study. Stroke 2008;39:3131-3136.
25. Dubourg O, Bourdarias JP, Farcot JC, et al. Contrast echocardiographic visualization of cough-induced right to left shunt through a patent foramen ovale. J Am Coll Cardiol 1984;4:587-594.
26. Falk RH. PFO or UFO? The role of a patent foramen ovale in cryptogenic stroke. Am Heart J 1991;121:1264-1266.
27. Eggebrecht H, Naber CK, Plato C, Erbel R, Bartel T. Analysis of fossa ovalis membrane velocities by transesophageal Doppler tissue echocardiography: a novel approach to functional assessment of patent foramen ovale. J Am Soc Echocardiogr 2004;17:1161-1166.
28. Somerville J, Khaliq SU, Brewer AC, Heath D. Clinical pathologic conference: paradoxical embolism, atrial septal defect, carcinoma of stomach. Am Heart J 1973;86:822-827.
29. Stollberger C, Slany J, Schuster I, Leitner H, Winkler WB, Karnik R. The prevalence of deep venous thrombosis in patients with suspected paradoxical embolism. Ann Intern Med 1993;119:461-465.
30. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 2003;139:753-760.
31. Berthet K, Lavergne T, Cohen A, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic stroke of unknown cause. Stroke 2000;31:398-403.
32. Mugge A, Daniel WG, Angermann C, et al. Atrial septal aneurysm in adult patients: a multicenter study using transthoracic and transesophageal echocardiography. Circulation 1995;91:2785-2792.
33. Kent DM, Trikalinos TA, Thaler DE. Patent foramen ovale and cryptogenic stroke. N Engl J Med 2008;358:1519-1520; author reply 1520-1511.
34. Orgera MA, O'Malley PG, Taylor AJ. Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review and meta-analysis. South Med J 2001;94:699-703.
35. Overell JR, Lees KR, Bone I. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism. Circulation 2001;103:E56.
36. Wu LA, Malouf JF, Dearani JA, et al. Patent foramen ovale in cryptogenic stroke: current understanding and management options. Arch Intern Med 2004;164:950-956.
37. Overell JR, Bone I, Lees KR. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 2000;55:1172-1179.
38. Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 2003;14:261-268.
39. Messe SR, Silverman IE, Kizer JR, et al. Practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2004;62:1042-1050.